ASCO 2017: Impact of perioperative chemotherapy and radiation for locally advanced penile squamous cell carcinoma
Chicago, IL (UroToday.com) Since penile squamous cell carcinoma (PSCC) is typically equated with orphan tumor status, there are a lack of clinical trials providing definitive evidence for treatment algorithms, particularly in the advanced state.
ASCO 2017: Penile Cancer: Current Evidence and Controversies
Chicago, IL (UroToday.com) Dr. Lance Pagliaro from the Mayo Clinic in Rochester provided a nice summary of penile cancer, a rare GU malignancy. His objectives were to provide an update regarding the current state of evidence and to highlight upcoming work and research. He started the talk by focusing on emerging therapeutics. As was the case in most of ASCO, the emphasis was on immune checkpoint blockade.
ASCO 2017: Multiregion sequencing of penile cancer to reveal distinct patterns of heterogeneous actionable mutations
Chicago, IL (UroToday.com) Penile cancer, particularly in the first world, remains a rare oncologic condition. Indeed, metastatic penile cancer is even more rare. This makes large studies in this disease process difficult to initiate. However, with such a poor prognosis once it has metastasized even to regional lymph nodes, additional therapeutic options are in desperate need.